These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11787243)

  • 41. Review of cytologic criteria of bacterial vaginosis: examination of 2,841 Papanicolaou-stained vaginal smears.
    Demirezen S
    Diagn Cytopathol; 2003 Sep; 29(3):156-9. PubMed ID: 12951684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess.
    Charonis G; Larsson PG
    Acta Obstet Gynecol Scand; 2009; 88(6):680-4. PubMed ID: 19412803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased sensitivity of Trichomonas vaginalis isolation from vaginal secretions by subsequent blind passage of preliminary negative cultures.
    Sakru N; Toz SO; Yetkin AC; Akinci PY; Kirca U
    Diagn Microbiol Infect Dis; 2005 May; 52(1):75-6. PubMed ID: 15878448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction between Trichomonas vaginalis and human spermatozoa in the female genital tract: Papanicolaou-stained cervical smear findings.
    Mali BN; Hazari KT; Meherji PK
    Acta Cytol; 2006; 50(3):357-9. PubMed ID: 16780038
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevalence of Trichomonas vaginalis infection in and around Surat.
    Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Trichomonas vaginalis].
    Piekarski G
    Dtsch Med Wochenschr; 1978 Jul; 103(27):1099-100. PubMed ID: 307485
    [No Abstract]   [Full Text] [Related]  

  • 47. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.
    Nye MB; Schwebke JR; Body BA
    Am J Obstet Gynecol; 2009 Feb; 200(2):188.e1-7. PubMed ID: 19185101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of intrauterine contraceptive devices on cytological findings from routine Pap smear testing.
    Kaplan B; Orvieto R; Hirsch M; Rabinerson D; Braslavski D; Bar-Hava I; Ben-Rafael Z
    Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):75-7. PubMed ID: 9710710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiological profile and biofilm formation on removed intrauterine contraceptive devices from a sample of Egyptian women.
    Abdel-Hafeez M; El-Mehallaway N; Khalil I; Abdallah F; Elnaggar A
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1770-6. PubMed ID: 24888947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The morphology of the endometrium, cytology of vaginal smears and sex hormone excretion of women following prolonged use of loop type intrauterine contraceptive devices].
    Latik IV
    Pediatr Akus Ginekol; 1972 Oct; 5():50-2. PubMed ID: 4658822
    [No Abstract]   [Full Text] [Related]  

  • 52. The diagnosis of Trichomonas vaginalis in liquid-based Pap tests: correlation with PCR.
    Aslan DL; Gulbahce HE; Stelow EB; Setty S; Brown CA; McGlennen RC; Pambuccian SE
    Diagn Cytopathol; 2005 Jun; 32(6):341-4. PubMed ID: 15880709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbiology of vaginitis associated with the intrauterine contraceptive device.
    Kivijärvi A; Järvinen H; Grönroos M
    Br J Obstet Gynaecol; 1984 Sep; 91(9):917-23. PubMed ID: 6332643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
    Yadav M; Gupta I; Malla N
    Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of bacterial vaginosis among women attending for intrauterine device insertion at an inner-city family planning clinic.
    Tosun I; Aydin F; Kaklikkaya N; Yazici Y
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):135-8. PubMed ID: 14667323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women.
    Torok MR; Miller WC; Hobbs MM; Macdonald PD; Leone PA; Schwebke JR; Sena AC
    J Infect Dis; 2007 Oct; 196(7):1102-7. PubMed ID: 17763335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mast cells in the tubal wall in women using an intrauterine contraceptive device.
    Sandvei R; Wollen AL; Flood PR; Anker C
    Br J Obstet Gynaecol; 1986 Jul; 93(7):758-64. PubMed ID: 3730347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenicity of Trichomonas vaginalis: cytopathologic and histopathologic changes of the cervical epithelium.
    Honigberg BM; Gupta PK; Spence MR; Frost JK; Kuczyńska K; Choromański L; Wartoń A
    Obstet Gynecol; 1984 Aug; 64(2):179-84. PubMed ID: 6377149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women.
    Malla N; Yadav M; Gupta I
    Parasite Immunol; 2007 Feb; 29(2):101-5. PubMed ID: 17241398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.